Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Evaluating the effects of residual neuromuscular block after surgery

Official title: Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications

Run by Hospital Universitario de Gran Canaria Doctor Negrín · NCT06386354 · Data updated 2026-11-12

This study looks at how leftover muscle weakness after surgery affects recovery and complications in patients who were given anesthesia with muscle relaxants.

More Postoperative Complications trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment296 (estimated)
SponsorHospital Universitario de Gran Canaria Doctor Negrín
Academic / other
Locations2 sites (Las Palmas de Gran Canaria, Las Palmas and 1 other locations)
StatusRecruiting
StartedMay 1, 2024
Main results expectedOctober 30, 2025
Study endsOctober 30, 2025
Registry record updatedAugust 24, 2025
Trial IDNCT06386354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients undergoing surgical procedures requiring general anesthesia with neuromuscular blockers who will be admitted to the hospital.

Probably not a fit

Patients with neuromuscular diseases or those who did not receive neuromuscular blockers during surgery will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the occurrence of residual neuromuscular blockade (RNMB) in patients who have undergone general anesthesia with neuromuscular blockers. It aims to assess the impact of RNMB on postoperative complications during hospital admission. By monitoring patients for one month after surgery, the study seeks to identify the prevalence of RNMB and its potential consequences on patient safety and recovery. The methodology includes the use of a train-of-four monitoring technique to evaluate neuromuscular function.

Why it matters

Potential benefit: If successful, this study could enhance postoperative care by reducing complications associated with residual neuromuscular blockade.

How similar studies have gone: Other studies have indicated the importance of monitoring neuromuscular blockade, suggesting that this approach could yield valuable insights into postoperative outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient undergoing surgical intervention under general anesthesia that requires the use of neuromuscular block during the study time and that required hospital admission.
* Informed consent signature.

Exclusion Criteria:

* Neuromuscular disease
* Not having received neuromuscular block during the intervention
* Admission to the outpatient surgery unit
* Admission to the postoperative intensive care unit
* Patients who signed informed consent, but postoperative data could not be collected upon arrival at the PACU.

Where it's running

  • Hospital Universitario de Gran Canaria Doctor Negrín
    Las Palmas de Gran Canaria, Las Palmas, Spain
    Recruiting
  • Ángel Becerra
    Las Palmas de Gran Canaria, Las Palmas, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.